Guardian Pharmacy Services, Inc. Class A ( (GRDN) ) has released its Q3 earnings. Here is a breakdown of the information Guardian Pharmacy Services, Inc. Class A presented to its investors.
Guardian Pharmacy Services, Inc., a prominent player in the long-term care pharmacy services sector, provides technology-enabled services to help residents in long-term health care facilities manage their medication regimens, improving clinical outcomes and reducing care costs.
In its third-quarter 2024 earnings report, Guardian Pharmacy Services highlighted a significant 20% year-over-year revenue increase to $314.4 million, driven by organic growth and the acquisition of Heartland Pharmacy. Despite strong revenue performance, the company reported a net loss of $105.8 million, largely due to substantial share-based compensation expenses related to their recent corporate reorganization and IPO.
Key financial metrics included an adjusted EBITDA rise of 20% to $23.0 million, excluding the impact of share-based compensation. The resident count also grew by 12%, reaching 180,000, attributed to both organic growth and the Heartland acquisition. For the nine months ending September 30, 2024, revenue rose by 16% to $889.8 million, with adjusted EBITDA increasing by 15% to $64.9 million.
Looking ahead, Guardian Pharmacy Services is optimistic about its growth trajectory, following its recent market expansion and acquisition activities. The company has set a full-year revenue guidance of between $1.205 billion and $1.215 billion, with adjusted EBITDA expected to be between $86.5 million and $87.0 million, laying a solid foundation for future growth as a public entity.
Trending Articles
- ‘Don’t Bet on a Losing Horse,’ Says Top Investor About Lucid Stock
- Will Plug Power Stock Rebound to $5? Here’s What BTIG Expects
- ‘Get Ready for the Next Leg Up,’ Says Piper Sandler About Nvidia Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
